Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1
Open Access
- 31 May 2020
- Vol. 12 (6), 1426
- https://doi.org/10.3390/cancers12061426
Abstract
The natural history of non-optic central nervous system (CNS) tumors in neurofibromatosis type 1 (NF1) is largely unknown. Here, we describe prevalence, clinical presentation, treatment, and outcome of 49 non-optic CNS tumors observed in 35 pediatric patients (0–18 years). Patient- and tumor-related data were recorded. Overall survival (OS) and progression-free survival (PFS) were evaluated. Eighteen patients (51%) harbored an optic pathway glioma (OPG) and eight (23%) had multiple non-optic CNS lesions. The majority of lesions (37/49) were managed with a wait-and-see strategy, with one regression and five reductions observed. Twenty-one lesions (42.9%) required surgical treatment. Five-year OS was 85.3%. Twenty-four patients progressed with a 5-year PFS of 41.4%. Patients with multiple low-grade gliomas progressed earlier and had a lower 5-year PFS than those with one lesion only (14.3% vs. 57.9%), irrespective of OPG co-presence. Non-optic CNS tumors are common in young patients with NF1. Neither age and symptoms at diagnosis nor tumor location influenced time to progression in our series. Patients with multiple lesions tended to have a lower age at onset and to progress earlier, but with a good OS.Keywords
This publication has 84 references indexed in Scilit:
- Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomasFamilial Cancer, 2012
- A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)Neuro-Oncology, 2010
- Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 PatientsJournal of Neuropathology and Experimental Neurology, 2008
- Moyamoya following cranial irradiation for primary brain tumors in childrenNeurology, 2007
- An Absence of Cutaneous Neurofibromas Associated with a 3-bp Inframe Deletion in Exon 17 of the NF1 Gene (c.2970-2972 delAAT): Evidence of a Clinically Significant NF1 Genotype-Phenotype CorrelationAmerican Journal of Human Genetics, 2007
- Second Primary Tumors in Neurofibromatosis 1 Patients Treated for Optic Glioma: Substantial Risks After RadiotherapyJournal of Clinical Oncology, 2006
- Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?PEDIATRICS, 1999
- An Association Between Optic Glioma and Other Tumours of the Central Nervous System in Neurofibromatosis Type 1Neuropediatrics, 1997
- Intracranial parenchymal schwannomaJournal of Neurosurgery, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958